Audubon, Pa.-based Globus Medical announced this week that it missed out on its estimated quarterly earnings per share by $0.02.
Here are five things to know:
1. Globus issued roughly $625 million of revenue guidance compared to the estimated $624.42 consensus revenue mark.
2. The company opened Wednesday, Feb. 28, 2017 at $27.81. Its one-year low is $19.25 and its one-year high is $28.86.
3. On Feb. 27, Globus reported $0.31 earnings per share for the quarter, missing the $0.33 estimate by $0.02. However, the company's revenue of $151.59 million for the quarter exceeded analysts' expectations of $149.30 million. Revenue for the quarter was up 6.3 percent on a year-over-year basis.
4. Zacks Investment Research, JMP Securities, Oppenheimer Holdings Inc., and William Blair recently cut shares of Globus.
5. One analyst has rated the company's stock with a sell rating, 10 have given a hold rating and three have given a buy rating. Globus has a consensus price target of $25.60.
More device articles:
10 things to know about Stryker
Drs. Dom Coric, Michael Fehlings to present on INSPIRE study: 4 insights